<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.1.1.5279
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
  <div>
    <div style="text-align: center; color: #000000; font-weight: bold;">As filed with the Securities and Exchange Commission on March 3, 2025</div>
    <div><br>
    </div>
    <div style="text-align: right; color: #000000; font-weight: bold;">Registration No. 333-</div>
    <div><font style="color: #000000;"> </font><br>
    </div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-size: 14pt; font-weight: bold;">UNITED STATES</div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>
    <div style="color: rgb(0, 0, 0); font-weight: bold;"> <br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-size: 18pt; font-weight: bold;">FORM S-8</div>
    <div><font style="color: #000000;"> </font><br>
    </div>
    <div style="text-align: center; color: #000000; font-weight: bold;">REGISTRATION STATEMENT</div>
    <div style="text-align: center; color: #000000; font-style: italic; font-weight: bold;">UNDER</div>
    <div style="text-align: center; color: #000000; font-style: italic; font-weight: bold;">THE SECURITIES ACT OF 1933</div>
    <div><br>
    </div>
    <div><font style="color: #000000;"> </font>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    <div style="text-align: center; color: rgb(0, 0, 0); font-size: 24pt; font-weight: bold;">Rocket Pharmaceuticals, Inc.</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">(Exact name of registrant as specified in its charter)</div>
    <div><br>
    </div>
    <div><font style="color: #000000;"> </font>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="z57f0c5c2606e47bf90ce599f35b6c27d" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 49%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Delaware</div>
          </td>
          <td style="width: 2%; vertical-align: bottom;">&#160;</td>
          <td style="width: 49%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">04-3475813</div>
          </td>
        </tr>
        <tr>
          <td style="width: 49%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(State or other jurisdiction of incorporation or organization)</div>
          </td>
          <td style="width: 2%; vertical-align: bottom;">&#160;</td>
          <td style="width: 49%; vertical-align: top;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(I.R.S. Employer Identification No.)</div>
          </td>
        </tr>

    </table>
    <div><font style="color: #000000;"> </font><br>
    </div>
    <div style="text-align: center; color: #000000; font-weight: bold;">Rocket Pharmaceuticals, Inc.</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">9 Cedarbrook Drive</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">Cranbury, NJ 08512</div>
    <div style="text-align: center; color: #000000;">(Address of principal executive offices, including zip code)</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">(646) 440-9100</div>
    <div style="text-align: center; color: #000000;">(Registrant&#8217;s telephone number, including area code)</div>
    <div><font style="color: #000000;"> </font><br>
    </div>
    <div style="text-align: center; color: #000000;"><font style="font-weight: bold;">Second Amended and Restated Rocket Pharmaceuticals, Inc.</font>&#160;<font style="font-weight: bold;">2014 Stock Option and Incentive Plan</font></div>
    <div style="text-align: center; color: #000000;">(Full title of the plan)</div>
    <div><br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    <div style="text-align: center; color: #000000; font-weight: bold;">Gaurav Shah, MD</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">President and Chief Executive Officer</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">Rocket Pharmaceuticals, Inc.</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">9 Cedarbrook Drive</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">Cranbury, NJ 08512</div>
    <div style="text-align: center; color: #000000;">(Name and address, including zip code, of agent for service)</div>
    <div style="text-align: center; color: #000000; font-weight: bold;">(646) 440-9100</div>
    <div style="text-align: center; color: #000000;">(Telephone number, including area code, of agent for service)</div>
    <div><br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    <div style="text-align: center; color: #000000; font-style: italic; font-weight: bold;">Please send copies of all communications to:</div>
    <div><font style="color: #000000;"> </font><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="zd577896c08614964b236f2b40c6b99e0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 49%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-weight: bold;">Whitney John Smith</div>
            <div style="text-align: center; color: #000000; font-weight: bold;">Sean M. Jones</div>
            <div style="text-align: center; color: #000000; font-weight: bold;">K&amp;L Gates LLP</div>
            <div style="text-align: center; color: #000000; font-weight: bold;">599 Lexington Avenue</div>
            <div style="text-align: center; color: #000000; font-weight: bold;">New York, NY 10022</div>
            <div style="text-align: center; color: #000000; font-weight: bold;">(212) 536-3930</div>
          </td>
          <td style="width: 2%; vertical-align: top;">&#160;</td>
          <td style="width: 49%; vertical-align: top;">
            <div style="text-align: center; color: #000000; font-weight: bold;">Martin Wilson</div>
            <div style="text-align: center; color: #000000; font-weight: bold;">General Counsel &amp; Chief Corporate Officer</div>
            <div style="text-align: center; color: #000000; font-weight: bold;">Rocket Pharmaceuticals, Inc.</div>
            <div style="text-align: center; color: #000000; font-weight: bold;">9 Cedarbrook Drive</div>
            <div style="text-align: center; color: #000000; font-weight: bold;">Cranbury, NJ 08512</div>
            <div style="text-align: center; color: #000000; font-weight: bold;">(646) 440-9100</div>
          </td>
        </tr>

    </table>
    <div><font style="color: #000000;"> </font><br>
    </div>
    <div style="text-align: justify; color: #000000;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions
      of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</div>
    <div><font style="color: #000000;"> </font><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="zdc4d09a31b7344b586d993b73021de3a" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 47%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">Large accelerated filer</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">&#9746;</div>
          </td>
          <td style="width: 47%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">Accelerated filer</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">&#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 47%; vertical-align: bottom;">&#160;</td>
          <td style="width: 3%; vertical-align: bottom;">&#160;</td>
          <td style="width: 47%; vertical-align: bottom;">&#160;</td>
          <td style="width: 3%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 47%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">Non-accelerated filer</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">&#9744;</div>
          </td>
          <td style="width: 47%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">Smaller reporting company</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">&#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 47%; vertical-align: bottom;">&#160;</td>
          <td style="width: 3%; vertical-align: bottom;">&#160;</td>
          <td style="width: 47%; vertical-align: bottom;">&#160;</td>
          <td style="width: 3%; vertical-align: bottom;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 47%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">Emerging growth company</div>
          </td>
          <td style="width: 3%; vertical-align: bottom;">
            <div style="color: rgb(0, 0, 0);">&#9744;</div>
          </td>
          <td style="width: 47%; vertical-align: bottom;">&#160;</td>
          <td style="width: 3%; vertical-align: bottom;">&#160;</td>
        </tr>

    </table>
    <div><font style="color: #000000;"> </font><br>
    </div>
    <div style="text-align: justify; color: #000000;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
      provided pursuant to Section 7(a)(2)(B) of the Securities Act. &#9744;</div>
    <div><font style="color: #000000;"> </font><br>
    </div>
    <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; color: #000000; font-weight: bold;">EXPLANATORY NOTE</div>
    <div><font style="color: #000000;"> </font><br>
      <div style="text-align: justify;"><font style="color: #000000;">This Registration Statement on Form S-8 registers 11,034,376 additional shares of Common Stock under the Second Amended and Restated Rocket Pharmaceuticals, Inc. 2014 Stock Option and
          Incentive Plan (the &#8220;<u>Plan</u>&#8221;). The number of shares of Common Stock reserved and available for issuance under the Plan is subject to an automatic annual increase on each January 1, beginning on January 1, 2019, by an amount equal to the
          lesser of: (i) four percent (4%) of the number of shares of Common Stock issued and outstanding on the immediately preceding December 31 or (ii) such number of shares of Common Stock as determined by the compensation committee of the Company&#8217;s
          board of directors. Accordingly, on January 1, 2023, January 1, 2024, and January 1, 2025, the number of shares of Common Stock reserved and available for issuance under the Plan increased by 3,164,932, 3,611,291 and 4,258,153 shares,
          respectively. The additional shares are of the same class as other securities relating to the Plan for which the Registrant&#8217;s registration statements filed on Form S-8 filed with the Securities and Exchange Commission on December 20, 2022 (</font><a href="https://www.sec.gov/Archives/edgar/data/1281895/000114036122046359/brhc10045666_s8.htm">File No. 333-268908</a><font style="color: #000000;">), March 6, 2020 (</font><a href="https://www.sec.gov/Archives/edgar/data/1281895/000114036120005062/forms8.htm">File No. 333-236946</a><font style="color: #000000;">), March 7, 2018 (</font><a href="https://www.sec.gov/Archives/edgar/data/1281895/000119312518073524/d527889ds8.htm">File No. 333-223488</a><font style="color: #000000;">), March 23, 2017 (</font><a href="https://www.sec.gov/Archives/edgar/data/1281895/000119312517092821/d361865ds8.htm">File No. 333-216892</a><font style="color: #000000;">), June 29, 2016 (</font><a href="https://www.sec.gov/Archives/edgar/data/1281895/000119312516636655/d218658ds8.htm">File No. 333-212308</a><font style="color: #000000;">) and May 28, 2015 (</font><a href="https://www.sec.gov/Archives/edgar/data/1281895/000119312515204038/d933094ds8.htm">File No. 333-204501</a><font style="color: #000000;">), are effective. The information contained in the Registrant&#8217;s registration statements on Form S-8
          (File Nos. </font><a href="https://www.sec.gov/Archives/edgar/data/1281895/000114036122046359/brhc10045666_s8.htm">333-268908</a><font style="color: #000000;">, </font><a href="https://www.sec.gov/Archives/edgar/data/1281895/000114036120005062/forms8.htm">333-236946</a><font style="color: #000000;">, </font><a href="https://www.sec.gov/Archives/edgar/data/1281895/000119312518073524/d527889ds8.htm">333- 223488</a><font style="color: #000000;">, </font><a href="https://www.sec.gov/Archives/edgar/data/1281895/000119312517092821/d361865ds8.htm">333-216892</a><font style="color: #000000;">, </font><a href="https://www.sec.gov/Archives/edgar/data/1281895/000119312516636655/d218658ds8.htm">333-212308</a><font style="color: #000000;"> and </font><a href="https://www.sec.gov/Archives/edgar/data/1281895/000119312515204038/d933094ds8.htm">333-204501</a><font style="color: #000000;">) are hereby incorporated by reference pursuant to General Instruction E.</font></div>
    </div>
  </div>
  <div><br>
    <div style="color: #000000; font-weight: bold;">Part II</div>
    <div><font style="color: #000000;"> </font><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z8f545440e5c24436993b58b1ca5143ab" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 100%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div>
      <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="z7528b45af2014c78b48b2ad731dff765" class="DSPFListTable">

          <tr style="vertical-align: top;">
            <td style="text-align: right; vertical-align: top; width: 99pt; font-weight: bold;">
              <div style="text-align: left;">Item 8.</div>
            </td>
            <td style="text-align: left; vertical-align: top; width: auto; font-weight: bold;">
              <div>Exhibits.</div>
            </td>
          </tr>

      </table>
    </div>
    <div>
      <div> <br>
      </div>
      <table cellspacing="0" cellpadding="0" id="z371694c985f540acbf79de1e66b0f0af" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

          <tr>
            <td style="width: 6.77%; vertical-align: bottom;">
              <div style="color: #000000; font-weight: bold;">Exhibit</div>
              <div style="color: #000000; font-weight: bold;">No.</div>
            </td>
            <td style="width: 93.23%; vertical-align: bottom;">
              <div style="text-align: center; color: #000000; font-weight: bold;">Description</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6.77%; vertical-align: top; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0);">
              <div><a href="ef20044742_ex5-1.htm">5.1*</a></div>
            </td>
            <td style="width: 93.23%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: #000000;">Opinion of K&amp;L Gates LLP.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6.77%; vertical-align: top;">
              <div style="color: #000000;">&#160;</div>
            </td>
            <td style="width: 93.23%; vertical-align: top;">
              <div style="color: #000000;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6.77%; vertical-align: top; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0);">
              <div><a href="ef20044742_ex5-1.htm">23.1*</a></div>
            </td>
            <td style="width: 93.23%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: #000000;">Consent of K&amp;L Gates LLP (included in Exhibit 5.1).</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6.77%; vertical-align: top;">
              <div style="color: #000000;">&#160;</div>
            </td>
            <td style="width: 93.23%; vertical-align: top;">
              <div style="color: #000000;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6.77%; vertical-align: top; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0);">
              <div><a href="ef20044742_ex23-2.htm">23.2*</a></div>
            </td>
            <td style="width: 93.23%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: #000000;">Consent of EisnerAmper LLP, independent registered public accounting firm.</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6.77%; vertical-align: top;">
              <div style="color: #000000;">&#160;</div>
            </td>
            <td style="width: 93.23%; vertical-align: top;">
              <div style="color: #000000;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6.77%; vertical-align: top; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0);">
              <div><a href="#POWEROFATTORNEYANDSIGNATU">24.1*</a></div>
            </td>
            <td style="width: 93.23%; vertical-align: top; background-color: #CCEEFF;">
              <div style="color: #000000;">Power of Attorney (included on signature page).</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6.77%; vertical-align: top;">
              <div style="color: #000000;">&#160;</div>
            </td>
            <td style="width: 93.23%; vertical-align: top;">
              <div style="color: #000000;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6.77%; vertical-align: top; background-color: #CCEEFF;">
              <div style="color: #0000EE;"><a href="https://www.sec.gov/Archives/edgar/data/1281895/000119312518143310/d535515ddef14a.htm">99.1</a></div>
            </td>
            <td style="width: 93.23%; vertical-align: top; background-color: #CCEEFF;">
              <div style="text-align: justify; color: #000000;">Second Amended and Restated 2014 Stock Option and Incentive Plan (Incorporated by reference to Appendix A to the Registrant&#8217;s Definitive Proxy Statement on Schedule 14A (File No. 001-36829)
                filed with the Securities and Exchange Commission on April 20, 2018).</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6.77%; vertical-align: top;">
              <div style="color: #000000;">&#160;</div>
            </td>
            <td style="width: 93.23%; vertical-align: top;">
              <div style="color: #000000;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6.77%; vertical-align: top; background-color: #CCEEFF;">
              <div style="color: #0000EE;"><a href="https://www.sec.gov/Archives/edgar/data/1281895/000114036118036347/ex10_2.htm">99.2</a></div>
            </td>
            <td style="width: 93.23%; vertical-align: top; background-color: #CCEEFF;">
              <div style="text-align: justify; color: #000000;">Form of Incentive Stock Option Agreement (Employees) (Incorporated by reference to Exhibit 10.3# to the Registrant&#8217;s Annual Report on Form 10-K (File No. 001-36829) filed with the Securities
                and Exchange Commission on March 8, 2019).</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6.77%; vertical-align: top;">
              <div style="color: #000000;">&#160;</div>
            </td>
            <td style="width: 93.23%; vertical-align: top;">
              <div style="color: #000000;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6.77%; vertical-align: top; background-color: #CCEEFF;">
              <div style="color: #0000EE;"><a href="https://www.sec.gov/Archives/edgar/data/1281895/000114036118036347/ex10_3.htm">99.3</a></div>
            </td>
            <td style="width: 93.23%; vertical-align: top; background-color: #CCEEFF;">
              <div style="text-align: justify; color: #000000;">Form of Non-Qualified Stock Option Agreement (Employees) (Incorporated by reference to Exhibit 10.4# to the Registrant&#8217;s Annual Report on Form 10-K (File No. 001-36829) filed with the
                Securities and Exchange Commission on March 8, 2019).</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6.77%; vertical-align: top;">
              <div style="color: #000000;">&#160;</div>
            </td>
            <td style="width: 93.23%; vertical-align: top;">
              <div style="color: #000000;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6.77%; vertical-align: top; background-color: #CCEEFF;">
              <div style="color: #0000EE;"><a href="https://www.sec.gov/Archives/edgar/data/1281895/000114036118036347/ex10_4.htm">99.4</a></div>
            </td>
            <td style="width: 93.23%; vertical-align: top; background-color: #CCEEFF;">
              <div style="text-align: justify; color: #000000;">Form of Non-Qualified Stock Option Agreement (Non-Employee Directors) (Incorporated by reference to Exhibit 10.5# to the Registrant&#8217;s Annual Report on Form 10-K (File No. 001-36829) filed with
                the Securities and Exchange Commission on March 8, 2019).</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6.77%; vertical-align: top;">
              <div style="color: #000000;">&#160;</div>
            </td>
            <td style="width: 93.23%; vertical-align: top;">
              <div style="color: #000000;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6.77%; vertical-align: top; background-color: #CCEEFF;">
              <div style="color: #0000EE;"><a href="https://www.sec.gov/Archives/edgar/data/1281895/000114036118036347/ex10_5.htm">99.5</a></div>
            </td>
            <td style="width: 93.23%; vertical-align: top; background-color: #CCEEFF;">
              <div style="text-align: justify; color: #000000;">Form of Non-Qualified Stock Option Agreement (Consultants) (Incorporated by reference to Exhibit 10.6# to the Registrant&#8217;s Annual Report on Form 10-K (File No. 001-36829) filed with the
                Securities and Exchange Commission on March 8, 2019).</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6.77%; vertical-align: top;">
              <div style="color: #000000;">&#160;</div>
            </td>
            <td style="width: 93.23%; vertical-align: top;">
              <div style="color: #000000;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6.77%; vertical-align: top; background-color: #CCEEFF;">
              <div style="color: #0000EE;"><a href="https://www.sec.gov/Archives/edgar/data/1281895/000114036120005056/ex10_61.htm">99.6</a></div>
            </td>
            <td style="width: 93.23%; vertical-align: top; background-color: #CCEEFF;">
              <div style="text-align: justify; color: #000000;">Form of Restricted Stock Unit Award Agreement (Incorporated by reference to Exhibit 10.6.1# to the Registrant&#8217;s Annual Report on Form 10-K (File No. 001-36829) filed with the Securities and
                Exchange Commission on March 1, 2021).</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6.77%; vertical-align: top;">
              <div style="color: #000000;">&#160;</div>
            </td>
            <td style="width: 93.23%; vertical-align: top;">
              <div style="color: #000000;">&#160;</div>
            </td>
          </tr>
          <tr>
            <td style="width: 6.77%; vertical-align: top; background-color: rgb(204, 238, 255); color: rgb(0, 0, 0);">
              <div><a href="ef20044742_ex107.htm">107*</a></div>
            </td>
            <td style="width: 93.23%; vertical-align: top; background-color: rgb(204, 238, 255);">
              <div style="color: #000000;">Filing Fee Table.</div>
            </td>
          </tr>

      </table>
    </div>
    <div><br>
    </div>
    <div>
      <hr noshade="noshade" align="left" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto 0px 0px; height: 2px; width: 10%; color: #000000;"></div>
    <div>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%;" id="z0949fb25855346a28d4a3e8146a1113b" class="DSPFListTable">

            <tr style="vertical-align: top;">
              <td style="text-align: right; vertical-align: top; width: 27pt;">
                <div style="text-align: left; color: rgb(0, 0, 0);">*</div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="color: rgb(0, 0, 0);">Filed herewith.</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; color: #000000; font-weight: bold;">SIGNATURES</div>
    <div><font style="color: #000000;"> </font><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: #000000;">Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for
      filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Cranbury, State of New Jersey, on March 3, 2025.</div>
    <div><font style="color: #000000;"> </font><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="zd38aa86fe31a4139ac2aeb8bce8f2f05" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>
          <td style="width: 98%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0); font-weight: bold;">ROCKET PHARMACEUTICALS, INC.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>
          <td style="width: 98%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 2%; vertical-align: top; padding-bottom: 2px;" colspan="1">&#160;</td>
          <td style="width: 98%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="color: rgb(0, 0, 0);">/s/ Gaurav Shah, MD</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>
          <td style="width: 98%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Gaurav Shah, MD</div>
          </td>
        </tr>
        <tr>
          <td style="width: 2%; vertical-align: top;" colspan="1">&#160;</td>
          <td style="width: 98%; vertical-align: top;">
            <div style="color: rgb(0, 0, 0);">Chief Executive Officer</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; color: #000000; font-weight: bold;"><a name="POWEROFATTORNEYANDSIGNATU"><!--Anchor--></a>POWER OF ATTORNEY AND SIGNATURES<!--Anchor--></div>
    <div><font style="color: #000000;"> </font><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: #000000;"><font style="font-weight: bold;">KNOW ALL PERSONS BY THESE PRESENTS</font>, that each person whose signature appears below hereby constitutes and appoints Gaurav Shah, MD and Martin
      Wilson, and each of them, as his or her true and lawful attorney-in-fact and agent with the full power of substitution, for him or her, in any and all capacities, to sign any and all amendments to this Registration Statement (including post-effective
      amendments to this Registration Statement on Form S-8), and to file the same, with all exhibits thereto and other documents in connection therewith, with the Commission, granting unto said attorneys-in-fact and agents, and each of them, full power
      and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said
      attorneys-in-fact and agents, or his or her substitutes, may lawfully do or cause to be done by virtue hereof.</div>
    <div><font style="color: #000000;"> </font><br>
    </div>
    <div style="text-align: justify; text-indent: 18pt; color: #000000;">Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons on behalf of the Registrant in the capacities and on the dates
      indicated:</div>
    <div><font style="color: #000000;"> </font><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="zd19220758f8042a880c2378c05039d49" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 31.99%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Name</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Title</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Date</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">/s/ Gaurav Shah, MD</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">Chief Executive Officer and Director</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">March 3, 2025</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">Gaurav Shah, MD</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">(Principal Executive Officer)</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">/s/ Aaron Ondrey</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">Chief Financial Officer</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">March 3, 2025</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">Aaron Ondrey</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">(Principal Financial Officer)</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">/s/ John Militello</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">VP, Finance, Senior Controller &amp; Treasurer</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">March 3, 2025</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">John Militello</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">(Principal Accounting Officer)</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">/s/ Elisabeth Bj&#246;rk</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">Elisabeth Bj&#246;rk</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">Director</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">March 3, 2025</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">/s/ Carsten Boess</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">Carsten Boess</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">Director</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">March 3, 2025</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">/s/ Mikael Dolsten</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">Mikael Dolsten</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">Director</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">March 3, 2025</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">/s/ Pedro Granadillo</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">Pedro Granadillo</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">Director</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">March 3, 2025</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">/s/ Gotham Makker, MD</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">Gotham Makker, MD</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">Director</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">March 3, 2025</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">/s/ Fady Malik</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">Fady Malik</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">Director</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">March 3, 2025</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">/s/ Piratip Pratumsuwan</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">Piratip Pratumsuwan</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">Director</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">March 3, 2025</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">/s/ David P. Southwell</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">David P. Southwell</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">Director</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">March 3, 2025</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">/s/ Roderick Wong, MD</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">Roderick Wong, MD</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">Director</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">March 3, 2025</div>
            </div>
          </td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">/s/ R. Keith Woods</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">&#160;</td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 31.99%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">R. Keith Woods</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 45%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">Director</div>
            </div>
          </td>
          <td style="width: 1%; vertical-align: top;">&#160;</td>
          <td style="width: 21%; vertical-align: top;">
            <div>
              <div style="text-align: center; color: rgb(0, 0, 0);">March 3, 2025</div>
            </div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
[{"type": "S-8", "sequence": "1", "filename": "ef20044742_s8.htm", "description": "S-8", "secsgml_size_bytes": 56598}]
{"company-data": {"conformed-name": "ROCKET PHARMACEUTICALS, INC.", "cik": "0001281895", "assigned-sic": "2834", "organization-name": "03 Life Sciences", "irs-number": "000000000", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-285520", "film-number": "25699615"}, "business-address": {"street1": "350 FIFTH AVENUE", "street2": "SUITE 7530", "city": "NEW YORK", "state": "NY", "zip": "10118", "phone": "646-440-9100"}, "mail-address": {"street1": "350 FIFTH AVENUE", "street2": "SUITE 7530", "city": "NEW YORK", "state": "NY", "zip": "10118"}, "former-company": {"former-conformed-name": "INOTEK PHARMACEUTICALS CORP", "date-changed": "20040226"}}
As filed with the Securities and Exchange Commission on March 3, 2025
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
Rocket Pharmaceuticals, Inc.
(Exact name of registrant as specified in its charter)
Delaware
04-3475813
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
Rocket Pharmaceuticals, Inc.
9 Cedarbrook Drive
Cranbury, NJ 08512
(Address of principal executive offices, including zip code)
(646) 440-9100
(Registrant's telephone number, including area code)
Second Amended and Restated Rocket Pharmaceuticals, Inc.
2014 Stock Option and Incentive Plan
(Full title of the plan)
Gaurav Shah, MD
President and Chief Executive Officer
Rocket Pharmaceuticals, Inc.
9 Cedarbrook Drive
Cranbury, NJ 08512
(Name and address, including zip code, of agent for service)
(646) 440-9100
(Telephone number, including area code, of agent for service)
Please send copies of all communications to:
Whitney John Smith
Sean M. Jones
K&L Gates LLP
599 Lexington Avenue
New York, NY 10022
(212) 536-3930
Martin Wilson
General Counsel & Chief Corporate Officer
Rocket Pharmaceuticals, Inc.
9 Cedarbrook Drive
Cranbury, NJ 08512
(646) 440-9100
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions
      of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☒
Accelerated filer
☐
Non-accelerated filer
☐
Smaller reporting company
☐
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
      provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
EXPLANATORY NOTE
This Registration Statement on Form S-8 registers 11,034,376 additional shares of Common Stock under the Second Amended and Restated Rocket Pharmaceuticals, Inc. 2014 Stock Option and
          Incentive Plan (the "
Plan
"). The number of shares of Common Stock reserved and available for issuance under the Plan is subject to an automatic annual increase on each January 1, beginning on January 1, 2019, by an amount equal to the
          lesser of: (i) four percent (4%) of the number of shares of Common Stock issued and outstanding on the immediately preceding December 31 or (ii) such number of shares of Common Stock as determined by the compensation committee of the Company's
          board of directors. Accordingly, on January 1, 2023, January 1, 2024, and January 1, 2025, the number of shares of Common Stock reserved and available for issuance under the Plan increased by 3,164,932, 3,611,291 and 4,258,153 shares,
          respectively. The additional shares are of the same class as other securities relating to the Plan for which the Registrant's registration statements filed on Form S-8 filed with the Securities and Exchange Commission on December 20, 2022 (
File No. 333-268908
), March 6, 2020 (
File No. 333-236946
), March 7, 2018 (
File No. 333-223488
), March 23, 2017 (
File No. 333-216892
), June 29, 2016 (
File No. 333-212308
) and May 28, 2015 (
File No. 333-204501
), are effective. The information contained in the Registrant's registration statements on Form S-8
          (File Nos.
333-268908
,
333-236946
,
333- 223488
,
333-216892
,
333-212308
and
333-204501
) are hereby incorporated by reference pursuant to General Instruction E.
Part II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 8.
Exhibits.
Exhibit
No.
Description
5.1*
Opinion of K&L Gates LLP.
23.1*
Consent of K&L Gates LLP (included in Exhibit 5.1).
23.2*
Consent of EisnerAmper LLP, independent registered public accounting firm.
24.1*
Power of Attorney (included on signature page).
99.1
Second Amended and Restated 2014 Stock Option and Incentive Plan (Incorporated by reference to Appendix A to the Registrant's Definitive Proxy Statement on Schedule 14A (File No. 001-36829)
                filed with the Securities and Exchange Commission on April 20, 2018).
99.2
Form of Incentive Stock Option Agreement (Employees) (Incorporated by reference to Exhibit 10.3# to the Registrant's Annual Report on Form 10-K (File No. 001-36829) filed with the Securities
                and Exchange Commission on March 8, 2019).
99.3
Form of Non-Qualified Stock Option Agreement (Employees) (Incorporated by reference to Exhibit 10.4# to the Registrant's Annual Report on Form 10-K (File No. 001-36829) filed with the
                Securities and Exchange Commission on March 8, 2019).
99.4
Form of Non-Qualified Stock Option Agreement (Non-Employee Directors) (Incorporated by reference to Exhibit 10.5# to the Registrant's Annual Report on Form 10-K (File No. 001-36829) filed with
                the Securities and Exchange Commission on March 8, 2019).
99.5
Form of Non-Qualified Stock Option Agreement (Consultants) (Incorporated by reference to Exhibit 10.6# to the Registrant's Annual Report on Form 10-K (File No. 001-36829) filed with the
                Securities and Exchange Commission on March 8, 2019).
99.6
Form of Restricted Stock Unit Award Agreement (Incorporated by reference to Exhibit 10.6.1# to the Registrant's Annual Report on Form 10-K (File No. 001-36829) filed with the Securities and
                Exchange Commission on March 1, 2021).
107*
Filing Fee Table.
*
Filed herewith.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for
      filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Cranbury, State of New Jersey, on March 3, 2025.
ROCKET PHARMACEUTICALS, INC.
/s/ Gaurav Shah, MD
Gaurav Shah, MD
Chief Executive Officer
POWER OF ATTORNEY AND SIGNATURES
KNOW ALL PERSONS BY THESE PRESENTS
, that each person whose signature appears below hereby constitutes and appoints Gaurav Shah, MD and Martin
      Wilson, and each of them, as his or her true and lawful attorney-in-fact and agent with the full power of substitution, for him or her, in any and all capacities, to sign any and all amendments to this Registration Statement (including post-effective
      amendments to this Registration Statement on Form S-8), and to file the same, with all exhibits thereto and other documents in connection therewith, with the Commission, granting unto said attorneys-in-fact and agents, and each of them, full power
      and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully for all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said
      attorneys-in-fact and agents, or his or her substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons on behalf of the Registrant in the capacities and on the dates
      indicated:
Name
Title
Date
/s/ Gaurav Shah, MD
Chief Executive Officer and Director
March 3, 2025
Gaurav Shah, MD
(Principal Executive Officer)
/s/ Aaron Ondrey
Chief Financial Officer
March 3, 2025
Aaron Ondrey
(Principal Financial Officer)
/s/ John Militello
VP, Finance, Senior Controller & Treasurer
March 3, 2025
John Militello
(Principal Accounting Officer)
/s/ Elisabeth Björk
Elisabeth Björk
Director
March 3, 2025
/s/ Carsten Boess
Carsten Boess
Director
March 3, 2025
/s/ Mikael Dolsten
Mikael Dolsten
Director
March 3, 2025
/s/ Pedro Granadillo
Pedro Granadillo
Director
March 3, 2025
/s/ Gotham Makker, MD
Gotham Makker, MD
Director
March 3, 2025
/s/ Fady Malik
Fady Malik
Director
March 3, 2025
/s/ Piratip Pratumsuwan
Piratip Pratumsuwan
Director
March 3, 2025
/s/ David P. Southwell
David P. Southwell
Director
March 3, 2025
/s/ Roderick Wong, MD
Roderick Wong, MD
Director
March 3, 2025
/s/ R. Keith Woods
R. Keith Woods
Director
March 3, 2025